WFSBP 2019 Final Program

55 Thursday, 6 June 2019 / Scientific Program WFSBP 2019 THU aa Thursday, 6 June 2019 T1: ADDICTIVE DISORDERS S-64 SYMPOSIUM 08:15–09:45 Ballroom B/C Behavioral addictions: Brain imaging findings and their translation to clinical practice Chair: Florence Thibaut, France Co-Chair: Aviv Weinstein, Israel 001 Structural and functional studies using MRI in individuals with gambling and cocaine-use disorder Marc Potenza, USA 002 Brain imaging studies on IGD and psychiatric co-morbidity Aviv Weinstein, Israel 003 Neuroimaging studies of sexual cue reactivity in individuals with compulsive sexual behaviors Valerie Voon, United Kingdom 004 The clinical implications of sex addiction and present pharmacological and brain stimulation studies on the treatment of sex addiction Florence Thibaut, France T7: BIPOLAR DISORDERS: BASIC/CLINICAL S-65 SYMPOSIUM 08:15–09:45 Ballroom A Update on Bipolar Disorders (BD): Clinical, neurobiological and therapeutic advances Chair: Gustavo Vazquez, Canada Co-Chair: Eduard Vieta, Spain 001 Clinical paradigms in the current diagnosis of Bipolar Disorders (BD) Eduard Vieta, Spain 002 Advances in the neurobiology of Bipolar Disorders (BD) Carlos Zarate, USA 003 Balancing risks and benefits for the pharmacologi- cal management of Bipolar Disorders (BD) Gustavo Vazquez, Canada 004 Innovative treatments for Bipolar Disorders (BD) Michael Berk, Australia T39: PHARMACOGENETICS S-67 SYMPOSIUM 08:15–09:45 East Meeting Room 13 Individualizing treatment modalities in psychiatry - The future is here Chair: George Patrinos, Greece Co-Chair: Martin Alda, Canada 001 Genomics of psychiatric diseases Dimitris Dikeos, Greece 002 Individualising lithium treatment for bipolar dis- ease patients Martin Alda, Canada 003 Precision phenotyping in treatment individualisa- tion for psychiatric patients Adrián Llerena, Spain 004 Preemptive pharmacogenomics in psychiatry: The PREPARE study George Patrinos, Greece T49: PSYCHOPHARMACOLOGY S-68 SYMPOSIUM 08:15–09:45 East Meeting Room 9 Cannabis, THC & CBD: From pharmacokinetics, behavioural and neurocognitive effects to clinical use Chair: Tomas Palenicek, Czech Republic Co-Chair: Amir Englund, United Kingdom 001 The acute effects of recreationally used cannabis on cognitive processing in occasional and chronic users: An ecologically valid study Tomas Palenicek, Czech Republic 002 Brain kinetics of neurometabolites underlying cognitive change during acute cannabis intoxication Johannes Ramaekers, The Netherlands 003 Can we make cannabis safer?: Exploring the effects of inhaled cannabis with 4 different THC:CBD ratios in healthy volunteers Amir Englund, United Kingdom 004 Safety, tolerability and efficacy of Cannabidiol in psychosis Mohini Ranganathan, USA